The role of protein kinase C (PKC) in mediating contractile responses in the rat vas deferens was studied. Phorbol-12,13-di-acetate (PDA) in the presence of 20 mM K+ elicited a concentration-dependent response with an EC50 of 190 nM. The non-PKC activator 4α-phorbol (2 μM) was unable to elicit contraction in 20 mM K+ buffer. Incubation of rat vas deferens with the PKC inhibitor iso-H7 (30 μM) attenuated the response to norepinephrine (NE) ane neurokinin A, with maximal effects depressed to 42 and 39% of control, respectively. Responses to 60 mM K+ and 2 μM PDA (20 mM K+) was also significantly inhibited by iso-H7. In the presence of 2 μM PDA and 20 mM K+, the NE concentration-effect curve was shifted 3,6-fold to the right of the control curve in a parallel manner. 4α-Phorbol (20 mM K+) at the same concentration did not produce this effect. These results suggest a significant role for PKC in the contractile response of the rat vas deferens.

No description available.

Submitted by Eunice Novais (enovais@uepg.br) on 2018-03-12T18:21:00Z No. of bitstreams: 2 license_rdf: 811 bytes, checksum: e39d27027a6cc9cb039ad269a5db8e34 (MD5) Luiza Stolz Cruz.pdf: 10331435 bytes, checksum: 9b1d4ec95714f86c9315354c7d388689 (MD5) / Made available in DSpace on 2018-03-12T18:21:00Z (GMT). No. of bitstreams: 2 license_rdf: 811 bytes, checksum: e39d27027a6cc9cb039ad269a5db8e34 (MD5) Luiza Stolz Cruz.pdf: 10331435 bytes, checksum: 9b1d4ec95714f86c9315354c7d388689 (MD5) Previous issue date: 2017-03-03 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / Euphorbia umbellata (Pax) Bruyns tem seu látex utilizado, etnofarmacologicamente, para tratamento de câncer, incluindo leucemias. Uma doença maligna que atinge os leucócitos, com alta incidência, sendo o tipo de câncer mais comum na infância. O tratamento quimioterápico é, na maioria dos casos, o mais recomendado, mas apresenta-se como terapia muito agressiva e com diversos efeitos colaterais. Por conseguinte, o objetivo deste trabalho foi o de avaliar o potencial citotóxico da fração hexano do látex de Euphorbia umbellata suas subfrações e da substância isolada, eufol, frente a linhagens modelo de leucemia. Para tanto as células, Jurkat e HL-60, foram tratadas por 72 horas com a fração hexano (1,25-75 μg/mL), subfrações éter de petróleo, diclorometano, etanol e metanol (1,25-75 μg/mL) e com o eufol (10-50 μg/mL), sendo sua viabilidade celular avaliada pelo ensaio de redução do MTT ao final deste período. Para a subfração diclorometano (mais ativa) foi avaliada a viabilidade celular no período de 24 e 48 horas, além de ter sido determinado o índice de seletividade. Cabe ressaltar que a fração hexano e as subfrações foram obtidas por fracionamento em extrator de Soxhlet, enquanto o eufol, por precipitação ácida, seguida de cromatografia em coluna, e sendo identificado por ressonância magnética nuclear e espectrometria de massas. A fração hexano e as subfrações resultantes foram analisadas por cromatografia gasosa acoplada ao espectrômetro de massas. A avaliação cromatográfica das subfrações permitiu sugerir 10 substâncias, os triterpenos: eufol; lanosterol; cicloartenol; tirucalol; taraxasterol e lupeol, os diterpenos: forbol-12,13,20- triacetato; 4-β forbol e 3-desoxo-3- 16-dihidroxi-12-desoxiforbol-3-13-16-20- tetracetato, e o esteroide sitosterol. Como resultado do ensaio citotóxico obteve-se, para a fração hexano uma CI50 de 0,061 ± 1,226 μg/mL para as células HL-60 e 4,624 ± 1,088 μg/mL para células Jurkat; para o eufol uma CI50 de 21,031 ± 1,778 μg/mL (HL-60) e 35,925 ± 5,011 μg/mL (Jurkat). Dentre as subfrações a diclorometano apresentou o melhor perfil de resposta com valores de 0,005±0,098 μg/mL (HL-60) e 0,200±0,957 μg/mL (Jurkat), revelando que o tratamento é tempo dependente. Ademais a subfração diclorometano mostrouse seletiva para o tratamento de leucemia com índices de seletividade superior a 2. Portanto, conclui-se que a subfração diclorometano é a promissora para o tratamento de leucemia, possivelmente por ação sinérgica dos terpenos nela presente. / Euphorbia umbellata (Pax) Bruyns has its latex used, ethno-pharmacologically, for the treatment of cancer, including leukemias. A malignant disease that affects leukocytes, with high incidence, being the most common type of cancer in childhood. Chemotherapy treatment is, normally, the most recommended, but it presents as very aggressive therapy and with several side effects. Therefore, the objective of this work was to evaluate the cytotoxic potential of the hexane fraction of Euphorbia umbellata latex, the subfraction of that and the isolated substance, euphol, against leukemia model lines. For this, the cells, Jurkat and HL-60, were treated for 72 hours with the hexane fraction (1.25-75 μg/mL), subfractions petroleum ether, dichloromethane, ethanol and methanol (1.25-75 μg/mL), and euphol (10-50 μg/mL), and their cell viability was evaluated by the assay of MTT reduction at the end of this period. For the dichloromethane subfraction (the most active), the cell viability was evaluated in the period of 24 and 48 hours, in addition, the selectivity index was determined. It should be noted that the hexane fraction and subfractions were obtained by fractionation in Soxhlet extractor, while euphol by acid precipitation, followed by column chromatography, and being identified by nuclear magnetic resonance and mass spectrometry. The hexane fraction was partitioned and the resulting subfractions were analyzed by gas chromatography coupled to the mass spectrometer. The chromatographic evaluation of the subfractions allowed to suggest 10 substances, the triterpenes: euphol; lanosterol; cycloartenol; tirucallol; taraxasterol and lupeol, the diterpenes: phorbol-12,13,20-triacetate; 4- β-phorbol and 3-deoxo-3-16-dihydroxy-12-deoxyphorbol-3-13-16-20-tetracetate, and the steroid sitosterol. As a result of the cytotoxic assay, an IC50 of 0.061 ± 1.226 μg/mL was obtained for HL-60 cells and 4.624 ± 1.088 μg/mL for Jurkat cells; and for euphol an IC50 of 21.031 ± 1.778 μg/ml (HL-60) and 35.925 ± 5.011 μg/ml (Jurkat). Among the subfractions, the dichloromethane presented the best response profile with values of 0,005±0,098 μg/mL (HL-60) and 0,200±0,957 μg/mL (Jurkat), revealing that the treatment is time dependent. In addition, the dichloromethane subfraction was selective for the treatment of leukemia with indexes of selectivity superior to 2.Therefore, it is concluded that the subfraction dichloromethane is promising for the treatment of leukemia, possibly by synergistic action of the terpenes in it.

<p>The Mad/Max/Myc transcription factor network takes part in the control of vital cellular functions such as growth, proliferation, differentiation and apoptosis. Dimerization with the protein Max is necessary for the Myc-family of oncoproteins and their antagonists, the Mad-family proteins, to regulate target genes and carry out their intended functions. Myc functions as a positive regulator of proliferation, antagonized by the growth inhibitory Mad-proteins that potentially functions as tumor supprerssors. Deregulated Myc expression is found in a variety of tumors and signals negatively regulating Myc expression and/or activity could therefore be of potential use in treating tumors with deregulated Myc.</p><p>Our aim was to therefore to investigate possible negative effects on Myc expression and activity by growth inhibitory cytokines and by the Myc antagonists, the Mad-family proteins.Two different cellular model systems of neuronal and hematopoietic origin have been utilized for these studies.</p><p>Our results show that Mad1 is upregulated during induced neuronal differentiation of SH-SY5Y cells. Further, the growth inhibitory cytokine interferon-g (IFN-g) was shown to cooperate with retinoic acid (RA) and the phorbol ester TPA in inducing growth arrest and differentiation in N-<i>myc</i> amplified neuroblastoma cell lines. In contrast to treatment with either agent alone, the combined treatment of TPA+IFN-g and RA+IFN-g led to upregulation of Mad1 and to downregulation of N-Myc, respectively, thus correlating with the enhanced growth inhibition and differentiation observed after combination treatment. Ectopic expression of an inducible Mad1 in monoblastic U-937 cells led to growth inhibition but did not lead to differentiation or enhancement of differentiation induced by RA, vitamin D3 or TPA. In v-Myc transformed U-937 cells Mad1 expression reestablished the TPA-induced G1 cell cycle arrest, but did not restore differentiation, blocked by v-Myc. The growth inhibitory cytokine TGF-b was found to induce Mad1 expression and Mad1:Max complex formation in v-Myc transformed U-937 cells correlating with reduced Myc activity and G1 arrest. </p><p>In conclusion, our results show that the Myc-antagonist Mad1 is upregulated by growth inhibitory cytokines and/or differentiation signals in neuronal and hematopoietic cells and that enforced Mad1 expression in hematopoietic cells results in growth inhibition and increased sensitivity to anti-proliferative cytokines. Mad1 and cytokine-induced signals therefore seem to cooperate in counteracting Myc activity.</p>

The Mad/Max/Myc transcription factor network takes part in the control of vital cellular functions such as growth, proliferation, differentiation and apoptosis. Dimerization with the protein Max is necessary for the Myc-family of oncoproteins and their antagonists, the Mad-family proteins, to regulate target genes and carry out their intended functions. Myc functions as a positive regulator of proliferation, antagonized by the growth inhibitory Mad-proteins that potentially functions as tumor supprerssors. Deregulated Myc expression is found in a variety of tumors and signals negatively regulating Myc expression and/or activity could therefore be of potential use in treating tumors with deregulated Myc. Our aim was to therefore to investigate possible negative effects on Myc expression and activity by growth inhibitory cytokines and by the Myc antagonists, the Mad-family proteins.Two different cellular model systems of neuronal and hematopoietic origin have been utilized for these studies. Our results show that Mad1 is upregulated during induced neuronal differentiation of SH-SY5Y cells. Further, the growth inhibitory cytokine interferon-g (IFN-g) was shown to cooperate with retinoic acid (RA) and the phorbol ester TPA in inducing growth arrest and differentiation in N-myc amplified neuroblastoma cell lines. In contrast to treatment with either agent alone, the combined treatment of TPA+IFN-g and RA+IFN-g led to upregulation of Mad1 and to downregulation of N-Myc, respectively, thus correlating with the enhanced growth inhibition and differentiation observed after combination treatment. Ectopic expression of an inducible Mad1 in monoblastic U-937 cells led to growth inhibition but did not lead to differentiation or enhancement of differentiation induced by RA, vitamin D3 or TPA. In v-Myc transformed U-937 cells Mad1 expression reestablished the TPA-induced G1 cell cycle arrest, but did not restore differentiation, blocked by v-Myc. The growth inhibitory cytokine TGF-b was found to induce Mad1 expression and Mad1:Max complex formation in v-Myc transformed U-937 cells correlating with reduced Myc activity and G1 arrest. In conclusion, our results show that the Myc-antagonist Mad1 is upregulated by growth inhibitory cytokines and/or differentiation signals in neuronal and hematopoietic cells and that enforced Mad1 expression in hematopoietic cells results in growth inhibition and increased sensitivity to anti-proliferative cytokines. Mad1 and cytokine-induced signals therefore seem to cooperate in counteracting Myc activity.

Thesis (Ph. D.)--Lunds universitet, 2005. / Title from title screen. Description based on contents viewed May 20, 2005. Includes bibliographical references (p. [36]-[48]).

Mycobacterium avium subsp. paratuberculosis (MAP) is a very slow growing bacterium that is the causative agent of Johne's disease (JD) in ruminants and has long been suggested to be associated with complications of Crohn's disease (CD) in humans. Although there is no direct evidence that MAP is the primary etiological agent for CD, most CD patients are found to have MAP in their intestinal tissues. The current control measures for JD in cattle, sheep, and goats have only been minimally effective, and there are only medications to treat the symptoms of mycobacterial infections associated with CD in humans. Along with not being able to cure MAP infections, there is no established laboratory animal model for testing therapeutics. When mice are infected with MAP they develop systemic infection and do not mimic disease observed in ruminants. J774A.1 murine macrophages typically have a very short lifespan of about 4-6 days, however MAP infected cell cultures can survive up to about 10 days. Using a modified protocol of Estrella et al. (2011), we have been able to establish a 45-60 day long-term MAP infected J774A.1 murine macrophage cell culture model. With the addition of retinoic acid (RA), vitamin D (VD), and phorbol myristate acetate (PMA) in combination in cell culture, we were able to screen novel therapeutics before embarking on in vivo testing in animals. This is a significant step forward in Crohn's and Johne's disease treatment research. We are not only able to test various drugs against specific strains of MAP to determine susceptibility, but we are also able to test a wide variety of drugs at the same time, with relatively minimal cost. We have evaluated the efficacy of clarithromycin, azithromycin, isoniazid, amikacin, ethambutol, ciprofloxacin, levofloxacin, rifampicin, clofazimine, as well as a combination of clarithromycin, rifampicin, and clofazimine using our MAP infected macrophage cell culture model. We were able to determine the drugs' differential ability to kill intracellular MAP in the early stages of infection, versus chronic stages of infection, and against two different strains of MAP, 43015 and 19698 that affect humans and cattle respectively. The minimal inhibitory concentration (MIC) of each drug was determined as per NCCLS protocol in vitro, and the drugs were tested at the MIC value, along with one concentration above and below the MIC in our cell culture model. The antimicrobials were found to be effective at different stages of cell culture infection and in different strains of MAP. Some drugs were more effective at early stages of MAP infection, whereas others were more effective in chronic or latent stages of infections. It is important to note that although a drug may be effective at a certain stage of infection, it may not necessarily be effective against all strains of MAP. The most promising results were seen with a combination of clarithromycin, clofazimine, and rifampicin, which was effective at all stages of infection with both strains of MAP tested. This long term cell culture model will provide researchers with important screening tools for evaluating new therapeutics before embarking on costly in vivo testing, and allow the assessment of therapeutics at different stages of MAP infection but also against an array of intracellular pathogens. / Ph. D.

Prostate cancer (PCa) represents the most frequently diagnosed cancer and the second leading cause of cancer death in males. Initial development and progression of the disease is mainly regulated by androgens. However, the pathology of the disease may progress to a loss of hormone dependence, resulting in rapid growth and a metastatic phenotype. Invasion and metastasis of tumour cells results from the degradation of the basement membrane (BM) and extracellular matrix (ECM). The degradation of the BM and ECM is in part mediated by a family of proteinases called the matrix metalloproteinases (MMPs). Currently more than 20 members of the MMP family have been identified and they are further divided in to sub-classes according to their protein structure. Collectively, MMPs are capable of degrading essentially all ECM components. High expression of some MMPs correlates with a malignant phenotype of various tumours. This study focused on the expression and regulation of a sub-class of MMPs called the membrane-type MMPs (MT-MMPs) in PCa. To date 6 MT-MMPs have been identified and they are characterized by a transmembrane domain, followed by a short cytoplasmic tail (MT1-, MT2-, MT3- and MT5-MMPs) or a glycosylphosphatidylinositol (GPI) moiety (MT4- and MT6-MMPs). MT-MMPs are thought to play a key role in tumour cell invasion by virtue of their ability to activate MMP-2 (a secreted MMP, which is implicated in many metastatic tumours) and their direct degradation activity on ECM components. Elevated MT-MMP expression has been shown in breast, colon, skin, stomach, lung, pancreas and brain cancers. Until very recently there had been no studies conducted on MT-MMPs in PCa. The few studies preceding or occurring in parallel with this one, have mainly reported the mRNA expression of these enzymes in PCa. Most studies have focused on MT1-MMP. Thus, at the commencement of this project there were many unexplored aspects of the expression and regulation of the broader MT-MMP family in PCa. The aims of this study were to examine: 1 a) The expression of MT-MMPs in prostate cancer cell lines using RT-PCR and western blot analysis and b) expression of MT1-MMP and MT5-MMP in BPH (benign prostatic hyperplasia) and PCa clinical tissue sections by immunohistochemistry. 2) The regulation of MT1-MMP, MT3-MMP and MT5-MMP in PCa cell lines by Concanavalin A (Con A), phorbol-12-myristate 13-acetate (PMA), dihydrotestosterone (DHT) and insulin-like growth factors I and II (IGF I and IGF II) using western blot analysis. In this study RWPE1, a transformed but non-tumorigenic prostate cell line was used as a "normal" prostate cell model, ALVA-41 and LNCaP as androgen-dependent PCa cell models and DU-145 and PC-3 as androgen-independent PCa cell models. The mRNA expression for the 6 MT-MMPs was determined by RT-PCR. The results indicate that MT1- and MT3-MMP were detected in all cell lines. This is the first study to report MT1-MMP mRNA expression in LNCaP cells and MT3-MMP mRNA in DU-145 cells. MT2-MMP mRNA was detected in only LNCaP and DU-145 cells, whilst MT5-MMP was detected in PC-3, DU-145 and LNCaP cells. nterestingly, MT2-, MT4-, MT5- or MT6-MMP mRNA expression was not detected in the "normal" cell line RWPE1, perhaps indicating an induction in gene transcription in tumour cells. MT4-MMP mRNA was only detected in the androgen-independent cell lines, indicating a potential role in the invasion and metastasis processes of the aggressive androgen-independent PCa. In this study, very low expression of MT6-MMP was detected only in LNCaP and DU-145 cells. Previously there had been no reports on the expression of MT6-MMP in the normal or cancerous prostate. Due to the mRNA of MT1-, MT3- and MT5-MMPs being the predominant MT-MMPs expressed in the current study, and the availability of suitable antibodies against them, the protein expression of these three MT-MMPs was studied by western blot analysis. MT1-, MT3- and MT5-MMP protein expression was detected in the cell lysates and conditioned medium (CM) of RWPE1, LNCaP and PC-3 cells. For each MT-MMP, various protein species were detected including putative proforms, mature (active) forms, processed or fragmented forms as well as soluble or shed forms. The presence of soluble or shed forms of MT-MMPs in the CM of cultures of "normal" and PCa cells could imply one of the following mechanisms: ectodomain shedding by either extracellular sheddases, the secretion of intracellular processed proteins without the transmembrane domain, the release of membrane vesicles containing membrane-bound enzymes, or the presence of alternatively spliced mRNA, which gives rise to MT-MMPs without a transmembrane domain. Further characterization of these various forms, including their amino acid sequence, is required to fully elucidate their structural composition. Despite the detection of the mRNA, we did not detect the cell-associated proteins of MT1-MMP and MT5-MMP and only very low expression of MT3-MMP in DU-145 cells (CM of DU-145 cells were not screened for soluble forms of the enzymes). This is the first study to report MT5-MMP expression at the protein level in prostate derived cell lines. Immunohistochemistry was carried out on benign prostatic hyperplasia (BPH) and PCa clinical tissues using MT1- and MT5-MMP antibodies to determine their cellular localisation in benign and cancer glands. MT1- and MT5-MMPs were expressed in BPH and moderate and high grade PCa. MT1-MMP expression was highest in moderate grade cancer compared to BPH and high grade cancer. MT1-MMP expression was predominantly observed in the cytoplasm of secretory epithelial cells of both benign and cancer glands, although in cancer glands, some nuclear staining was also observed. Stromal expression of MT1-MMP was only observed in high grade cancer. This study is the first to report the immunolocalization of MT5-MMP outside the brain and in kidneys of diabetic patients. MT5-MMP was predominantly expressed in the cytoplasm of the secretory cells in benign glands. In the cancer glands, staining was heterogeneous with low to intense staining, mainly in the nuclei, plasma membrane and cytoplasm of secretory epithelial cells. Stromal expression of MT5-MMP was only observed in cancer tissues, particularly in high grade cancer. To study the regulation of MT-MMPs in PCa, we treated LNCaP and PC-3 cells, with either Con A, PMA, DHT or IGF-I and -II and studied the protein expression of MT1-, MT3- and MT5-MMPs by western blot analysis. Con A and PMA have been shown to stimulate MMP expression in other cell systems. Con A treatment showed a general increase in the protein expression of MT1-, MT3- and MT5-MMPs. By far the greatest induction by Con A observed was the nearly 4 fold increase in MT5-MMP expression caused by 40μg/mL Con A treatment of PC-3 cells. PMA treatment of LNCaP and PC-3 cells appeared to increase shedding or secretion of all three MT-MMPs in to the CM. This increase in the soluble forms corresponded to a decrease in cell-associated forms in LNCaP cells. Treatment of LNCaP with DHT alone and treatment of LNCaP and PC-3 cells with IGF-I and -II alone failed to detect any change in expression of MT1-MMP. The information gathered in this study on MT-MMPs with respect to cellular localization, expression levels and regulation by growth factors or chemicals that mimic their actions, will aid in our understanding of the role of MT-MMPs in PCa. This study provides strong preliminary data for further research, particularly with respect to functional studies of MT-MMPs in PCa. Understanding the processes which govern the actions of such proteins as these will provide potential insights into development of new management and therapeutic regimens to prevent cancer progression.

CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior / Jatropha curcas L. is a plant native to America and belongs to the Euphorbiaceae family. Currently it is gaining economical interest mainly because it is an oilseed crop with potential to produce biodiesel. However, presence of phorbol esters (a class of diterpenes) that are the major toxic constituents of the seeds, limits a better usage of the plant, by making the use of the residue, obtained after the oil extraction from the seeds, unfeasible for animal feed, due to its pro-carcinogenic activity and inflammatory action. Proteomic analysis of the plastids isolated from developing seeds of Jatropha is important because the synthesis of fatty acid as well as phorbol esters, the two most attractive compounds in the study of Jatropha curcas, occur in plastids. Proteomic analysis of this organelle is crucial to better understand and explore not only the biosynthetic pathway of these two compounds but other metabolic pathways , and addtionaly providing foundation for researchs that aimed to develope genotypes with more suitable characteristics for industrial applications. In this study, we performed a proteomic analysis of plastids isolated from the endosperm of developing Jatropha curcas seeds that were in the initial stage of deposition of protein and lipid reserves. Proteins extracted from the plastids were digested with trypsin, and the peptides were applied to an EASY-nano LC system coupled online to an ESI-LTQ-Orbitrap Velos mass spectrometer, and this led to the identification of 1103 proteins representing 804 protein groups, of which 923 were considered as true identifications, and this considerably expands the repertoire of J. curcas proteins identified so far. Of the identified proteins, only five are encoded in the plastid genome, and none of them are involved in photosynthesis, evidentiating the nonphotosynthetic nature of the isolated plastids. Homologues for 824 out of 923 identified proteins were present in three different plastids proteins databases i.e. PPDB, SUBA and PlProt, while homologues for 13 proteins were not found in any of these three databases but were marked as plastidial by at least one of the three prediction programs used (TargetP, ChloroP and PlantMPloc). Functional classification showed that proteins belonging to amino acids metabolism comprise the main functional class, followed by carbohydrate, energy, and lipid metabolisms. The small and large subunits of Rubisco were identified, and their presence in plastids is considered to be an adaptive feature counterbalancing for the loss of one-third of the carbon as CO2 as a result of the conversion of carbohydrate to oil through glycolysis. While several enzymes involved in the biosynthesis of several precursors of diterpenoids were identified, we were unable to identify any terpene synthase/cyclase, which suggests that the plastids isolated from the endosperm of developing seeds do not synthesize phorbol esters. In conclusion, this study provides insights into the major biosynthetic pathways and certain unique features of the plastids from the endosperm of developing seeds at the whole proteome level. / O pinhÃo manso (Jatropha curcas L.) à uma planta nativa da AmÃrica, pertencente à famÃlia Euphorbiaceae. Atualmente, ela desperta interesse econÃmico principalmente por se tratar de uma oleaginosa com potencial para a produÃÃo de biodiesel. Entretanto, a presenÃa de Ãsteres de forbol (uma classe de diterpeno), que sÃo os principais constituintes tÃxicos das sementes, limita uma melhor utilizaÃÃo dessa planta, por inviabilizar o uso do resÃduo de extraÃÃo do Ãleo das sementes na alimentaÃÃo animal, bem como, por apresentar atividade prÃ-carcinogÃnica e aÃÃo inflamatÃria. A anÃlise proteÃmica de plastÃdeos, isolados de sementes em desenvolvimento de pinhÃo manso, à uma importante vertente de estudo, pois tanto a sÃntese de Ãcidos graxos como dos Ãsteres de forbol, os dois compostos mais atrativos no estudo de Jatropha curcas, ocorrem nos plastÃdeos. O estudo proteÃmico dessa organela torna-se crucial para melhor compreender e explorar nÃo somente as vias biossintÃticas desses dois compostos, como de outras vias metabÃlicas, alÃm de proporcionar um conjunto de dados que pode ser utilizado em pesquisas voltadas para o desenvolvimento de genÃtipos com caracterÃsticas mais adequadas para aplicaÃÃes industriais. No presente trabalho, realizou-se uma anÃlise proteÃmica de plastÃdeos isolados do endosperma de sementes em desenvolvimento do pinhÃo manso, que estavam nos estÃgios iniciais de deposiÃÃo de lipÃdios e proteÃnas de reserva (25-30DAA), confirmados por meio de anÃlises histolÃgica e histoquÃmica. As proteÃnas extraÃdas dos plastÃdeos foram digeridas com tripsina e os peptÃdeos foram aplicados no sistema de nano-LC EASYII acoplado online ao espectrÃmetro de massa nano ESI LTQ-Orbitrap velos, o que resultou na identificaÃÃo 1103 proteÃnas, representando 804 grupos de proteÃnas, dos quais 923 foram consideradas identificaÃÃes verdadeiras. Isso expandiu consideravelmente o repertÃrio de proteÃnas do pinhÃo manso atà agora identificas. Dentre as proteÃnas identificadas, apenas 5 sÃo codificadas pelo genoma plastidial, e nenhuma delas està envolvida na fotossÃntese, o que evidencia a natureza nÃo fotossintÃtica dos plastÃdeos isolados. HomÃlogos de 824, dentre as 923 proteÃnas identificadas, estavam presentes nos bancos de dados PPDB, SUBA e PlProt, enquanto homÃlogos para 13 proteÃnas nÃo foram encontrados em nenhum dos trÃs bancos de dados plastidiais, mas foram detectados como plastidiais por pelo menos um dos trÃs programas de prediÃÃo de localizaÃÃo subcelular utilizados (TargetP, ChloroP, PlantMPloc). A classificaÃÃo funcional mostrou que a maioria das proteÃnas identificadas pertencia ao metabolismo dos aminoÃcidos, seguido dos metabolismos dos carboidratos, energÃtico e dos lipÃdios. As subunidades maiores e menores da Rubisco foram identificadas, e sua presenÃa nos plastÃdeos foi considerada uma caracterÃstica adaptativa para contrabalancear a perda de um terÃo do carbono na forma de CO2 como um resultado da conversÃo de carboidratos em Ãleo atravÃs da glicÃlise. Apesar de enzimas envolvidas na biossÃntese de diversos precursores dos diterpenÃides terem sido identificadas, nÃo foi detectado nenhuma terpeno sintase/ciclase, o que sugere que os plastÃdeos isolados do endosperma de sementes em desenvolvimento nÃo sintetizam Ãsteres de forbol, apesar de uma grande quantidade desse composto ser encontrada neste tecido. Como conclusÃo, o presente trabalho proporciona insights sobre as principais vias biossÃntÃticas, e sobre caracterÃsticas peculiares dos plastideos isolados do endosperma de sementes em desenvolvimento.

No description available.